Maeda, Masahiro
Yamashita, Satoshi
Shimazu, Taichi
Iida, Naoko
Takeshima, Hideyuki
Nakajima, Takeshi
Oda, Ichiro
Nanjo, Sohachi
Kusano, Chika
Mori, Akiko
Moro, Hiroshi
Yamada, Harumi
Tsugane, Shoichiro
Sugiyama, Toshiro
Sakai, Yoshiharu
Ushijima, Toshikazu
Funding for this research was provided by:
Japan Agency for Medical Research and Development (15ck0106023h0002, 16ck0106023h0003, 17ck0106267h0001)
Article History
Received: 19 October 2017
Accepted: 27 January 2018
First Online: 9 February 2018
Compliance with ethical standards
:
: MM and TU made a joint patent application with Sysmex Corporation for identified epigenetic markers.
: All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1964 and later versions. Informed consent or substitute for it was obtained from all patients for being included in the study.
Free to read: This content has been made available to all.